Stimulation of m1 muscarinic receptors is associated with a second messenger cascade that previous workers have proposed proceeds as follows: Stimulated receptors coupled via G proteins activate phospholipase C stimulating the production of IP3 which liberates Ca+2 from cellular stores which stimulates NOS to hydrolyze L-arginine and form NO and L-citrulline. NO stimulates the enzyme guanylate cyclase to form cyclic GMP. The applicant presents hypotheses and data to support the hypotheses that this scheme may not be totally correct, at least in a causal sense. In particular, the accumulation of L-citrulline occurs over many minutes while the levels of NO and cyclic GMP rise and fall transiently. The applicant plans to use a newly developed microelectrode to accurately and sensitively measure NO and to correlate the time courses and dose-response curves for these three parameters in the hopes of more fully understanding the interrelationships. Additionally, the applicant proposes that the stimulation of NOS has an early and a late phase with the former being mediated by IP3-dependent and the latter being mediated by IP3-independent pathways. Preliminary data presented supports this hypothesis and a series of experiments to further test it are proposed. The applicant also proposes to study the phenomenon of agonist-induced desensitization of NOS. This desensitization appears to occur rapidly (minutes) and is manifested by a blunted cyclic GMP response. On the other hand, in this same rapid time frame, receptor stimulation of L-citrulline accumulation is not blunted. Experiments will be conducted in which NO is directly measured and this parameter compared to the others with the goal to test the hypothesis that agonist-induced desensitization of NO generation is due to a decrease in the coupling of the receptor to one or more of the steps in the signalling pathway involved in the elevation of Ca+2. Finally, a phenomenon is described in which cells incubated for 48 hours with agonist have an increased response to rechallenge by agonist. Experiments to examine the mechanism of this anomalous result are proposed. It is hypothesized, and the preliminary data support, that an increase in NOS protein and perhaps an increase in the sensitivity of the enzyme to Ca+2 are involved.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS025743-11
Application #
2455744
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Baughman, Robert W
Project Start
1988-12-01
Project End
2002-01-31
Budget Start
1998-02-01
Budget End
1999-01-31
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Psychiatry
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Jakubik, Jan; Janickova, Helena; Randakova, Alena et al. (2011) Subtype differences in pre-coupling of muscarinic acetylcholine receptors. PLoS One 6:e27732
Jakubík, J; Janí?ková, H; El-Fakahany, E E et al. (2011) Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy. Br J Pharmacol 162:1029-44
Grant, Marianne K O; Noetzel, Meredith J; De Lorme, Kayla C et al. (2010) Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor. PLoS One 5:e15722
Jakubík, Jan; El-Fakahany, Esam E (2010) Allosteric Modulation of Muscarinic Acetylcholine Receptors. Pharmaceuticals (Basel) 3:2838-2860
Michal, Pavel; Rudajev, Vladimír; El-Fakahany, Esam E et al. (2009) Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways. Eur J Pharmacol 606:50-60
Cabadak, Hulya; Cuadra, Adolfo E; El-Fakahany, Esam E et al. (2009) M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder. J Recept Signal Transduct Res 29:63-6
Noetzel, Meredith J; Grant, Marianne K O; El-Fakahany, Esam E (2009) Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor. Neurochem Res 34:1138-49
Noetzel, Meredith J; Grant, Marianne K O; El-Fakahany, Esam E (2009) Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding. Pharmacology 83:301-17
Kane, Brian E; Grant, Marianne K O; El-Fakahany, Esam E et al. (2008) Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor. Bioorg Med Chem 16:1376-92
De Lorme, Kayla C; Grant, Marianne K O; Noetzel, Meredith J et al. (2007) Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex. J Pharmacol Exp Ther 323:868-76

Showing the most recent 10 out of 93 publications